Statement: TAK in der Nachsorge von Schilddrüsenkrebspatienten (Verburg 2013)
Linkkategorien
- Alle Links
- SHG-Gruppen, -Foren und Organisationen
- Praxen, Kliniken und Pharmazie
- Themen-Kategorien
- SD-Allgemein
- SD-Autoimmun
- SD-OP
- SD-Krebs
- SD-Krebs medullär
- SD-Substitution
- RJT (Krebs)
- RJT (heiße Knoten)
- SD-Krebs anapl.
- SD-Krebs wenig-dif.
- Jod
- Neben-SD
- Krebs
- Alternative Thrp.
- Psyche u Krebs
- Psyche u SD
- Allg. med. Portale
- Qualität
- Palliativmedizin
- Stimmbandnerven
- Studien
- Nachsorge
- Leitlinien
- Eisen
- Kinder
- Fatigue
- Patientenrechte
- Lymphödeme
- Calcitonin
- Speicheldrüsen
- Studien, laufende
- Verein - Intern
Original-Titel:
Implications of Thyroglobulin Antibody Positivity in Patients with Differentiated Thyroid Cancer: A Clinical Position Statement
In:
Thyroid. October 2013, 23(10): 1211-1225.
doi:10.1089/thy.2012.0606.
Autoren:
Frederik A. Verburg,1 Markus Luster,2 Cristina Cupini,3 Luca Chiovato,4 Leonidas Duntas,5 Rossella Elisei,6 Ulla Feldt-Rasmussen,7 Harald Rimmele,8 Ettore Seregni,9 Johannes W.A. Smit,10 Christian Theimer,11 and Luca Giovanella12,13
- Department of Nuclear Medicine, University Hospital Aachen, Aachen, Germany.
- Department of Nuclear Medicine, University Hospital Ulm, Ulm, Germany.
- Endocrine Outpatient Clinic, University Hospital Pisa, Pisa, Italy.
- Department of Internal Medicine and Endocrinology, Salvatore Maugeri
- Foundation Research Hospital (IRCCS), University of Pavia Hospital, Pavia, Italy.
- Endocrine Unit, Evgenidion Hospital, University of Athens Medical School, Athens, Greece.
- Department of Endocrinology, University Hospital Pisa, Pisa, Italy.
- Department of Endocrinology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.
- Ohne Schilddrüse leben e.V., Thyroid Cancer Association (Bundesverband Schilddrüsenkrebs), Berlin, Germany.
- Department of Endocrinology, Cancer Institute, Milan, Italy.
- Department of Endocrinology, University Medical Center St. Radboud, Nijmegen, The Netherlands.
- B·R·A·H·M·S GmbH, Thermo Fisher Scientific Inc., Hennigsdorf, Germany.
- Department of Nuclear Medicine and PET Center, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
- Department of Laboratory Medicine EOLAB, Cantonal Hospital Authority, Bellinzona, Switzerland.
Verknüpfte Inhalte:
Statement: TAK in der Nachsorge des differenzierten Schilddrüsenkrebs (15.10.2013)